Byrne Asset Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-760
Closed -$12.7K 570
2024
Q3
$12.7K Buy
760
+40
+6% +$860 0.01% 356
2024
Q2
$14.8K Buy
720
+40
+6% +$866 0.01% 324
2024
Q1
$16.8K Buy
680
+380
+127% +$11.3K 0.01% 315
2023
Q4
$11.4K Buy
300
+20
+7% +$770 0.01% 344
2023
Q3
$14K Buy
280
+20
+8% +$1.19K 0.01% 312
2023
Q2
$18K Sell
260
-60
-19% -$3.87K 0.01% 342
2023
Q1
$16K Buy
320
+113
+55% +$5.97K 0.01% 342
2022
Q4
$12.5K Buy
+207
New +$12.1K 0.01% 361

Other funds holding PRTA

Byrne Asset Management's PRTA Position: Q4 2024 in Review

Byrne Asset Management sold out of Prothena Corp (PRTA) in Q4 2024, closing a stake of 760 shares — an estimated $12.7K sold.

Byrne Asset Management first reported a position in PRTA in Q4 2022 and held it in 8 quarters. The position peaked at $18K in Q2 2023. 170 funds tracked by Wall St. Rank hold PRTA as of Q4 2024.

  • Byrne Asset Management reported no remaining Prothena Corp position as of Q4 2024 after selling out during the quarter.
  • Byrne Asset Management sold 760 Prothena Corp shares in Q4 2024, an estimated $12.7K.
  • Byrne Asset Management first reported a position in Prothena Corp in Q4 2022 and held it in 8 quarters.
  • Byrne Asset Management's Prothena Corp position peaked at $18K in Q2 2023.
  • 170 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2024.

Based on Byrne Asset Management's 13F filing for Q4 2024, filed 28 Jan 2025.